End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3 NZD | -4.15% | -2.91% | -14.29% |
May. 01 | AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV | MT |
Apr. 24 | New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.29% | 187M | |
+30.30% | 699B | |
+25.07% | 571B | |
-4.37% | 364B | |
+18.36% | 326B | |
+3.61% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.39% | 154B |
- Stock Market
- Equities
- AFT Stock
- News AFT Pharmaceuticals Limited
- AFT Pharmaceuticals to Expand Global Footprint with Signing of Supply, Production Deals